Explore
Trendline
Argenx Acquires Forte Biosciences to Enhance Autoimmune Disease Portfolio
Argenx Acquires Forte Biosciences to Enhance Autoimmune Disease Portfolio
Read More
Trendline
Argenx Acquires Forte Biosciences for $2.2 Billion to Expand Immunology Pipeline
Argenx Acquires Forte Biosciences for $2.2 Billion to Expand Immunology Pipeline
Read More
Trendline
Precision BioSciences Announces Leadership Changes to Advance Clinical Programs
Precision BioSciences Announces Leadership Changes to Advance Clinical Programs
Read More
Trendline
Mapfre's $1.54 Billion Acquisition of Safety Insurance Group Involves Major Law Firms
Mapfre's $1.54 Billion Acquisition of Safety Insurance Group Involves Major Law Firms
Read More
Trendline
GeoVax Labs Reports Q2 Loss and Advances Vaccine Study
GeoVax Labs Reports Q2 Loss and Advances Vaccine Study
Read More
Trendline
Sarepta Therapeutics Names Michael Severino as CEO Amid Leadership Transition
Sarepta Therapeutics Names Michael Severino as CEO Amid Leadership Transition
Read More
Trendline
Tonix Pharmaceuticals to Announce Q2 2026 Financial Results Amid Expanding Treatment Portfolio
Tonix Pharmaceuticals to Announce Q2 2026 Financial Results Amid Expanding Treatment Portfolio
Read More
Trendline
Sanofi Halts Atopic Dermatitis Trials Following Efficacy Concerns
Sanofi Halts Atopic Dermatitis Trials Following Efficacy Concerns
Read More
Trendline
Paramount Delays Warner Bros. Merger Pending Antitrust Trial Outcome
Paramount Delays Warner Bros. Merger Pending Antitrust Trial Outcome
Read More
Trendline
Paramount Delays Warner Brothers Takeover Amid Legal Challenges
Paramount Delays Warner Brothers Takeover Amid Legal Challenges
Read More
Trendline
Paramount Delays Warner Bros. Discovery Acquisition Amid Legal Challenge
Paramount Delays Warner Bros. Discovery Acquisition Amid Legal Challenge
Read More
Trendline
Paramount's Warner Bros. Merger Faces Legal Challenges, Delaying Completion
Paramount's Warner Bros. Merger Faces Legal Challenges, Delaying Completion
Read More
